Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
08 mars 2019 10h01 HE | Intrommune Therapeutics
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
Harpoon_logo (002).jpg
Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
07 mars 2019 16h05 HE | Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers,...
NetworkNewsWire.jpg
BriaCell Therapeutics Corp. Highlights Recent Clinical and Scientific Achievements in Exclusive Audio Interview with NetworkNewsWire
07 mars 2019 06h30 HE | NetworkNewsWire
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness...
TodosMedical.png
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage...
Glioblastoma brain tumour
CCAB announces creation of new brain cancer therapeutic company, Empirica Therapeutics, as part of its strategy to advance new early-stage life sciences companies TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) today announced a license agreement with Empirica Therapeutics Inc. aimed at...
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
20 févr. 2019 07h30 HE | Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers,...
Intensity Therapeutics, Inc.
Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference
05 févr. 2019 07h35 HE | Intensity Therapeutics Inc
WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase...
400dpiLogoCropped.jpg
Innovest Global Adds $600,000 to Call Center Contract
01 févr. 2019 09h00 HE | Innovest Global, Inc
CLEVELAND, Ohio, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and...